Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets.".